InsiderTrades.com logo

TLSI Insider Trading

Insider Ownership Percentage: 27.50%
Insider Buying (Last 12 Months): $544,606.66
Insider Selling (Last 12 Months): $83,527.50

TriSalus Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at TriSalus Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TriSalus Life Sciences Share Price & Price History

Current Price: $6.70
Price Change: ▲ Price Increase of +0.27 (4.20%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for TLSI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

TriSalus Life Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/19/2025Bryan F CoxInsiderSell4,764$5.18$24,677.52119,415View SEC Filing Icon  
5/19/2025Jodi DevlinInsiderSell4,764$5.18$24,677.5252,764View SEC Filing Icon  
5/19/2025Richard MarshakInsiderSell6,597$5.18$34,172.4669,101View SEC Filing Icon  
2/5/2025James Emmett YoungCFOBuy6,000$5.65$33,900.0030,000View SEC Filing Icon  
1/29/2025Mary T SzelaCEOBuy5,030$5.03$25,300.90439,249View SEC Filing Icon  
1/27/2025James Emmett YoungCFOBuy24,000$5.40$129,600.0024,000View SEC Filing Icon  
1/27/2025Mary T SzelaCEOBuy4,826$5.42$26,156.92429,503View SEC Filing Icon  
1/27/2025Sean MurphyInsiderBuy15,000$5.31$79,650.00182,732View SEC Filing Icon  
12/17/2024Equity Ab FrankeniusMajor ShareholderBuy62,972$3.97$249,998.846,230,748View SEC Filing Icon  
11/22/2024Mats WahlstromDirectorBuy5,000$4.55$22,750.0015,727View SEC Filing Icon  
11/20/2024Mats WahlstromDirectorBuy2,040$4.16$8,486.402,040View SEC Filing Icon  
10/5/2024Bryan F CoxInsiderSell314$4.44$1,394.1686,382View SEC Filing Icon  
9/12/2024Mary T SzelaCEOBuy7,520$5.20$39,104.00377,382View SEC Filing Icon  
9/10/2024Mary T SzelaCEOBuy5,000$4.97$24,850.00369,862View SEC Filing Icon  
8/28/2024George Kelly MartinDirectorSell9$5.50$49.50247,176View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for TriSalus Life Sciences (NASDAQ:TLSI)

2.58% of TriSalus Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TLSI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TriSalus Life Sciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Nantahala Capital Management LLC2,040,245$9.49M0.3%+2.0%4.091%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC35,612$0.17M0.0%+17.7%0.071%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC69,500$0.32M0.0%-7.8%0.139%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC73,706$0.34M0.0%N/A0.148%Search for SEC Filing on Google Icon
11/10/2025White Pine Capital LLC59,733$0.28M0.1%N/A0.120%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.1,159,575$5.39M0.0%+42.4%2.325%Search for SEC Filing on Google Icon
10/29/2025Sequoia Financial Advisors LLC19,456$90K0.0%N/A0.039%Search for SEC Filing on Google Icon
10/22/2025CWA Asset Management Group LLC72,000$0.34M0.0%N/A0.144%Search for SEC Filing on Google Icon
8/15/2025Gilder Gagnon Howe & Co. LLC1,092,975$5.96M0.1%+32.1%2.888%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC75,400$0.41M0.0%+16.0%0.199%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE188,906$1.03M0.0%+1.8%0.499%Search for SEC Filing on Google Icon
8/15/2025AWM Investment Company Inc.1,250,000$6.81M0.8%N/A3.303%Search for SEC Filing on Google Icon
8/14/2025Nantahala Capital Management LLC2,000,000$10.90M0.4%N/A5.286%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.8,705$47K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund19,800$0.11M0.0%N/A0.052%Search for SEC Filing on Google Icon
8/13/2025Connective Capital Management LLC32,796$0.18M0.2%+12.8%0.087%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.7,540$41K0.0%+35,804.8%0.020%Search for SEC Filing on Google Icon
8/8/2025Police & Firemen s Retirement System of New Jersey5,400$29K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC455,051$2.48M0.0%+107.4%1.203%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.33,900$0.19M0.0%N/A0.090%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.33,900$0.19M0.0%N/A0.105%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.10,000$55K0.0%N/A0.031%Search for SEC Filing on Google Icon
2/18/2025Connecticut Wealth Management LLC22,303$0.11M0.0%-32.2%0.073%Search for SEC Filing on Google Icon
2/18/2025Connective Capital Management LLC27,989$0.14M0.2%N/A0.092%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC80,538$0.40M0.0%-17.7%0.264%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC65,000$0.33M0.0%+333.3%0.213%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE178,446$0.89M0.0%+120,471.6%0.585%Search for SEC Filing on Google Icon
2/17/2025Angelo Gordon & CO. L.P.10,854$54K0.0%-48.0%0.036%Search for SEC Filing on Google Icon
2/14/2025Lido Advisors LLC14,024$70K0.0%-60.0%0.046%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp32,112$0.16M0.0%+22.7%0.105%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC13,400$67K0.0%N/A0.044%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC204,137$1.02M0.0%+1.9%0.670%Search for SEC Filing on Google Icon
11/20/2024Virtu Financial LLC19,875$92K0.0%N/A0.065%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC200,427$0.92M0.0%+45.4%0.657%Search for SEC Filing on Google Icon
11/15/2024Vestcor Inc23,376$0.11M0.0%N/A0.077%Search for SEC Filing on Google Icon
11/15/2024MSD Partners L.P.39,999$0.18M0.1%N/A0.131%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC14,376$66K0.0%N/A0.047%Search for SEC Filing on Google Icon
8/15/2024Duquesne Family Office LLC426,921$2.36M0.1%+35.1%1.572%Search for SEC Filing on Google Icon
8/12/2024Highbridge Capital Management LLC214,545$1.18M0.0%N/A0.790%Search for SEC Filing on Google Icon
8/2/2024Wolverine Asset Management LLC43,480$0.24M0.0%N/A0.160%Search for SEC Filing on Google Icon
5/7/2024Anson Capital Inc.24,415$0.24M0.3%-30.3%0.091%Search for SEC Filing on Google Icon
5/1/2024Connecticut Wealth Management LLC44,606$0.44M0.0%-22.0%0.167%Search for SEC Filing on Google Icon
4/23/2024Tyche Wealth Partners LLC10,000$98K0.0%-62.5%0.037%Search for SEC Filing on Google Icon
1/30/2024Tyche Wealth Partners LLC26,664$0.23M0.1%N/A0.101%Search for SEC Filing on Google Icon
1/25/2024HC Advisors LLC101,736$0.86M0.5%N/A0.387%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TriSalus Life Sciences logo
TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.
Read More on TriSalus Life Sciences

Today's Range

Now: $6.70
Low: $6.41
High: $6.87

50 Day Range

MA: $5.01
Low: $4.00
High: $7.00

52 Week Range

Now: $6.70
Low: $3.42
High: $7.32

Volume

95,468 shs

Average Volume

150,211 shs

Market Capitalization

$334.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.43

Who are the company insiders with the largest holdings of TriSalus Life Sciences?

TriSalus Life Sciences' top insider shareholders include:
  1. Equity Ab Frankenius (Major Shareholder)
  2. Mary T Szela (CEO)
  3. George Kelly Martin (Director)
  4. Sean Murphy (Insider)
  5. Bryan F Cox (Insider)
  6. Richard Marshak (Insider)
  7. Jodi Devlin (Insider)
  8. James Emmett Young (CFO)
  9. Mats Wahlstrom (Director)
Learn More about top insider investors at TriSalus Life Sciences.

Who are the major institutional investors of TriSalus Life Sciences?

TriSalus Life Sciences' top institutional shareholders include:
  1. Nantahala Capital Management LLC — 4.09%
  2. Vanguard Group Inc. — 2.33%
  3. Squarepoint Ops LLC — 0.15%
  4. CWA Asset Management Group LLC — 0.14%
  5. Bridgeway Capital Management LLC — 0.14%
  6. White Pine Capital LLC — 0.12%
Learn More about top institutional investors of TriSalus Life Sciences stock.

Which major investors are selling TriSalus Life Sciences stock?

During the previous quarter, TLSI stock was sold by these institutional investors:
  1. Bridgeway Capital Management LLC
In the last year, company insiders that have sold TriSalus Life Sciences company stock include:
  1. Equity Ab Frankenius (Major Shareholder)
  2. Mary T Szela (CEO)
  3. George Kelly Martin (Director)
Learn More investors selling TriSalus Life Sciences stock.

Which major investors are buying TriSalus Life Sciences stock?

Within the last quarter, TLSI stock was bought by institutional investors including:
  1. Vanguard Group Inc.
  2. Squarepoint Ops LLC
  3. CWA Asset Management Group LLC
  4. White Pine Capital LLC
  5. Nantahala Capital Management LLC
  6. Sequoia Financial Advisors LLC
  7. Millennium Management LLC
In the previous year, these company insiders have bought TriSalus Life Sciences stock:
  1. Equity Ab Frankenius (Major Shareholder)
  2. Mary T Szela (CEO)
  3. George Kelly Martin (Director)
  4. Sean Murphy (Insider)
  5. Bryan F Cox (Insider)
Learn More investors buying TriSalus Life Sciences stock.